Moolec Science SA (MLEC)
0.85
0.00 (0.00%)
USD |
NASDAQ |
Nov 05, 16:00
Moolec Science Enterprise Value
Enterprise Value Chart
Historical Enterprise Value Data
| Date | Value |
|---|---|
| November 05, 2026 | 20.77M |
| November 04, 2026 | 20.77M |
| November 03, 2026 | 20.77M |
| November 02, 2026 | 20.77M |
| October 30, 2026 | 21.17M |
| October 29, 2026 | 21.15M |
| October 28, 2026 | 21.25M |
| October 27, 2026 | 21.22M |
| October 26, 2026 | 21.26M |
| October 23, 2026 | 21.40M |
| October 22, 2026 | 21.38M |
| October 21, 2026 | 21.37M |
| October 20, 2026 | 21.32M |
| October 19, 2026 | 21.27M |
| October 16, 2026 | 21.37M |
| October 15, 2026 | 21.51M |
| October 14, 2026 | 21.51M |
| October 13, 2026 | 21.40M |
| October 12, 2026 | 21.46M |
| October 09, 2026 | 21.75M |
| October 08, 2026 | 23.20M |
| October 07, 2026 | 23.65M |
| October 06, 2026 | 23.66M |
| October 05, 2026 | 23.68M |
| October 02, 2026 | 23.60M |
| Date | Value |
|---|---|
| October 01, 2026 | 23.65M |
| September 30, 2026 | 23.70M |
| September 29, 2026 | 23.78M |
| September 28, 2026 | 23.73M |
| September 25, 2026 | 24.22M |
| September 24, 2026 | 24.40M |
| September 23, 2026 | 24.70M |
| September 22, 2026 | 24.18M |
| September 21, 2026 | 24.15M |
| September 18, 2026 | 24.58M |
| September 17, 2026 | 24.68M |
| September 16, 2026 | 24.53M |
| September 15, 2026 | 24.96M |
| September 14, 2026 | 25.31M |
| September 11, 2026 | 25.26M |
| September 10, 2026 | 25.52M |
| September 09, 2026 | 24.99M |
| September 08, 2026 | 25.18M |
| September 04, 2026 | 25.18M |
| September 03, 2026 | 25.34M |
| September 02, 2026 | 25.10M |
| September 01, 2026 | 25.16M |
| August 31, 2026 | 25.09M |
| August 28, 2026 | 25.09M |
| August 27, 2026 | 25.10M |
Enterprise Value Definition
EV is considered the theoretical purchase ("takeover") price of a business because a purchaser would take on the company's debt, while pocketing the company's cash and gaining a right to all of the company's future earnings.
Enterprise Value Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Enterprise Value Benchmarks
| Arcadia Biosciences, Inc. | -3.814M |
| Zivo Bioscience, Inc. | 34.68M |
| PMGC Holdings, Inc. | -4.452M |
| TFA Therapeutics, Inc. | -- |
| Archer-Daniels-Midland Co. | 38.26B |